Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | Director | May 08, 2026 | May 12, 2026 |
| PROCTER & GAMBLE CoPG · Entity 2814 | CEO - Health Care | December 03, 2025 | December 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 3,643 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 1,118 · Balance 3,643 F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
PROCTER & GAMBLE Co
Report date December 03, 2025 · Filed December 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,828.5086 |
Reported balance
After 2025-12-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-12-03 · Exercise / conversion · Acquired 60.43 · Balance 61,828.5086 F1: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. |
| Common StockSEC Table I · non-derivative | Direct | 61,768.0786 |
Reported balance
After 2025-12-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-12-03 · Tax withholding · Disposed 60.43 · Balance 61,768.0786 F2: Shares withheld to cover taxes on previous Restricted Stock Unit grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 262.6603 |
Reported balance
After 2025-11-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-17 · Grant · Acquired 33.9576 · Balance 262.6603 F3: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 965.57 |
Reported balance
After 2025-12-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-12-03 · Exercise / conversion · Disposed 60.43 · Balance 965.57 F5: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025. F4: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |
| Common StockSEC Table I · non-derivative | IndirectBy Retirement Plan Trustee | 15,535.3029 |
Reported balance
Holding disclosure · report date 2025-12-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 15,535.3029 |
Filing footnotes · ownership attribution and instrument terms
F1: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F2: Shares withheld to cover taxes on previous Restricted Stock Unit grant.
F3: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F4: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
F5: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2026 Filed May 12, 2026 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001916665-26-000002 · form4-05122026_050507.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,643 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 15:22 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionRestricted Stock Units · Derivative | 60.43 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000271 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 965.57 Underlying: Common Stock · 60.43 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 15:22 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 60.43 | $144.35 | $8,723.07 |
DisclosureSEC source: 0000080424-25-000271 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,768.0786 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 15:22 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 60.43 | $144.35 | $8,723.07 |
DisclosureSEC source: 0000080424-25-000271 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,828.5086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 17, 2025 Filed Dec 5, 2025 15:22 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 33.9576 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000271 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262.6603 Underlying: Common Stock · 33.9576 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 18:53 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 3,227 | $152.23 | $491,251.70 |
DisclosureSEC source: 0000080424-25-000204 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,763.9326 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:56 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 68,869 | $0.00 Strike: $153.18 | $0.00 |
DisclosureSEC source: 0000080424-25-000194 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,869 Underlying: Common Stock · 68,869 shares Expires 2035-10-01 Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 16:34 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 8,596 | $157.27 | $1,351,925.58 |
DisclosureSEC source: 0000080424-25-000138 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,990.9326 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 23:03 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 21,518 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000125 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,586.9326 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 15, 2025 Filed Aug 20, 2025 23:03 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 24.9443 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000125 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228.7027 Underlying: Common Stock · 24.9443 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 07, 2025 Filed Aug 7, 2025 17:53 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000085 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,026 Underlying: Common Stock · 1,026 shares Expires not disclosed F7 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| July 14, 2025 Filed Aug 7, 2025 17:53 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantSeries A Preferred Stock · Derivative | 0.6323 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000085 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 4,351.7444 Underlying: Common Stock · 0.6323 shares Expires not disclosed F5 · derivative.exercise_price: Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock. F6 · derivative.exercise_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. F6 · derivative.expiration_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Read SEC document |
| May 15, 2025 Filed Aug 7, 2025 17:53 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 23.8723 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-25-000085 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203.7584 Underlying: Common Stock · 23.8723 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012796 · form4-05132025_050509.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,525 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 17:45 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 1,000 | $161.38 | $161,384.00 |
DisclosureSEC source: 0001127602-25-012786 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,964.9178 F1 · price: Weighted average price of the shares sold. The price range was $161.38 to $161.40. Full information regarding the number of shares sold at each separate price available upon request. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 18, 2025 Filed Apr 30, 2025 17:45 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 22.1597 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012786 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179.8861 Underlying: Common Stock · 22.1597 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 17:47 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionRestricted Stock Units · Derivative | 46.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029843 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 736.73 Underlying: Common Stock · 46.27 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2024. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 17:47 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 46.27 | $169.79 | $7,856.18 |
DisclosureSEC source: 0001127602-24-029843 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,917.7015 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 17:47 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 46.27 | $169.79 | $7,856.18 |
DisclosureSEC source: 0001127602-24-029843 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,963.9715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 15, 2024 Filed Dec 20, 2024 17:47 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 21.6833 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029843 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157.7264 Underlying: Common Stock · 21.6833 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 4,447 | $171.65 | $763,345.78 |
DisclosureSEC source: 0001127602-24-025122 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,872.0851 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 56,554 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025122 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,554 Underlying: Common Stock · 56,554 shares Expires 2034-09-29 Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:59 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 6,223 | $169.22 | $1,053,049.84 |
DisclosureSEC source: 0001127602-24-022803 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,319.0851 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:56 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 15,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022626 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,437.2367 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 15, 2024 Filed Aug 22, 2024 20:59 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 16.9625 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022803 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136.0431 Underlying: Common Stock · 16.9625 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 21:51 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021676 · form4.xml · derivative · entry 6 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 783 Underlying: Common Stock · 783 shares Expires not disclosed F7 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2024. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| July 16, 2024 Filed Aug 5, 2024 21:51 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantSeries A Preferred Stock · Derivative | 103.9225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021676 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 4,351.1121 Underlying: Common Stock · 103.9225 shares Expires not disclosed F5 · derivative.exercise_price: Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock. F6 · derivative.exercise_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. F6 · derivative.expiration_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Read SEC document |
| May 15, 2024 Filed Aug 5, 2024 21:51 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 17.0954 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021676 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119.0806 Underlying: Common Stock · 17.0954 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 03, 2024 Filed May 8, 2024 00:16 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012558 · form4-05082024_120518.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,322 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| February 15, 2024 Filed Aug 5, 2024 21:51 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 16.8058 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021676 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101.9852 Underlying: Common Stock · 16.8058 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:55 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionRestricted Stock Units · Derivative | 47.5786 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743.4214 Underlying: Common Stock · 47.5786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:55 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 47.5786 | $149.40 | $7,108.24 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,255.6418 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:55 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 47.5786 | $149.40 | $7,108.24 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,303.2204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 15, 2023 Filed Dec 8, 2023 15:55 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 17.5915 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85.1794 Underlying: Common Stock · 17.5915 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:15 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 52,251 | $0.00 Strike: $145.19 | $0.00 |
DisclosureSEC source: 0001127602-23-025454 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,251 Underlying: Common Stock · 52,251 shares Expires 2033-09-30 Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:58 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 5,761 | $152.85 | $880,546.38 |
DisclosureSEC source: 0001127602-23-022998 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,148.7198 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:16 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 12,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022908 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,909.7198 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:16 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 12.2891 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022908 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67.5879 Underlying: Common Stock · 12.2891 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 03, 2023 Filed Aug 5, 2023 00:23 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022047 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 791 Underlying: Common Stock · 791 shares Expires not disclosed F7 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| July 11, 2023 Filed Aug 5, 2023 00:23 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantSeries A Preferred Stock · Derivative | 108.6909 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022047 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 4,247.1896 Underlying: Common Stock · 108.6909 shares Expires not disclosed F5 · derivative.exercise_price: Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock. F6 · derivative.exercise_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. F6 · derivative.expiration_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Read SEC document |
| May 15, 2023 Filed Aug 5, 2023 00:23 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 12.1777 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022047 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55.2988 Underlying: Common Stock · 12.1777 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:21 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,943 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,943 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:21 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 23,943 | $155.27 | $3,717,629.61 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,860.3494 Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 17:21 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 23,943 | $78.52 | $1,880,004.36 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,803.3494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 15, 2023 Filed Apr 25, 2023 17:21 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 13.1852 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013505 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43.1211 Underlying: Common Stock · 13.1852 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 18:09 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionRestricted Stock Units · Derivative | 37.4691 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027145 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585.5309 Underlying: Common Stock · 37.4691 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2022. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 18:09 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 37.4691 | $149.18 | $5,589.64 |
DisclosureSEC source: 0001127602-22-027145 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,749.1363 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 18:09 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 37.4691 | $149.18 | $5,589.64 |
DisclosureSEC source: 0001127602-22-027145 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,786.6054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 15, 2022 Filed Dec 9, 2022 18:09 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 13.086 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027145 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29.9359 Underlying: Common Stock · 13.086 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:30 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 29,198 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023552 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,198 Underlying: Common Stock · 29,198 shares Expires 2032-10-01 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.